Evaluation of UDP-glucose as a Urinary Biomarker for Early Detection of Cardiac Surgery-associated Pediatric Acute Kidney Injury



Status:Recruiting
Conditions:Renal Impairment / Chronic Kidney Disease, Hospital
Therapuetic Areas:Nephrology / Urology, Other
Healthy:No
Age Range:Any - 8
Updated:11/17/2018
Start Date:October 25, 2017
End Date:August 1, 2019
Contact:Douglas Atkinson, MD
Email:Douglas.Atkinson@childrens.harvard.edu
Phone:617-355-6225

Use our guide to learn which trials are right for you!

Acute kidney injury (AKI) is common in children after cardiac surgery with a reported
incidence of 20-40%. Pediatric AKI has been found to be associated with important short and
long-term adverse outcomes.

A major challenge to management of AKI after cardiac surgery and cardiopulmonary bypass is
the lack of early diagnostic markers. Current diagnostic criteria for AKI in children relies
exclusively on elevation of serum creatinine concentration and oliguria. Both of these
markers lack sensitivity and specificity, and result in delayed detection of kidney injury.

This study aims to determine if UDP-glucose can be used as a urinary biomarker to detect
subclinical acute kidney injury following pediatric cardiac surgery with cardiopulmonary
bypass.


Inclusion Criteria:

- less than or equal to 8 years of age

- scheduled for cardiac surgery

Exclusion Criteria:

- severe pre-existing renal insufficiency
We found this trial at
1
site
300 Longwood Ave
Boston, Massachusetts 02115
(617) 355-6000
Phone: 617-355-6225
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
?
mi
from
Boston, MA
Click here to add this to my saved trials